


期刊介绍
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists. Addresses a wide range of pharmacologic and oncologic concerns Focuses on new anticancer agents, screening, toxicology, drug administration modalities and clinical trials Offers results in related fields: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
癌症化学疗法和药理学在实验和临床水平上解决了广泛的药理学和肿瘤学问题。这种快速 发布介质的主要重点是新的抗癌药,其实验筛选,临床前毒理学和药理学,单一和联合给 药方式以及临床I,II和III期试验。 该期刊发表记录在以下领域的结果:临床毒理学,药代动力学,药效学,药物相互作用以 及癌症治疗策略中化学疗法的适应症。癌症化学疗法和药理学是药理学家和肿瘤学家必读 的书籍。。
癌症化学疗法和药理学在实验和临床水平上解决了广泛的药理学和肿瘤学问题。这种快速 发布介质的主要重点是新的抗癌药,其实验筛选,临床前毒理学和药理学,单一和联合给 药方式以及临床I,II和III期试验。 该期刊发表记录在以下领域的结果:临床毒理学,药代动力学,药效学,药物相互作用以 及癌症治疗策略中化学疗法的适应症。癌症化学疗法和药理学是药理学家和肿瘤学家必读 的书籍。。
全名/缩写 | CANCER CHEMOTH PHARM/CANCER CHEMOTHERAPY AND PHARMACOLOGY |
期刊ISSN | 0344-5704 |
2022-2023影响因子 | 3.000 实时影响因子查询 (由greensci.net提供-2019 New!) |
最新自引率 | 3.30 |
期刊官方网站 | http://link.springer.com/journal/280 |
是否OA开放访问 | No |
出版国家或地区 | UNITED STATES |
出版年份 | 1978 |
中科院JCR分区 | 大类:3区小类:4区 |
SCI期刊coverage |
Science Citation Index Science Citation Index Expanded |
审稿速度(网友添加,非官方) | 平均2.5月 |
×
绿色通道审稿 加急发表
可添加微信号:meibisi123